249.78MMarket Cap-4.51P/E (TTM)
0.8798High0.8230Low5.25MVolume0.8600Open0.8524Pre Close4.46MTurnover1.83%Turnover RatioLossP/E (Static)291.32MShares2.105052wk High6.17P/B246.36MFloat Cap0.370052wk Low--Dividend TTM287.33MShs Float778.1999Historical High--Div YieldTTM6.66%Amplitude0.1700Historical Low0.8500Avg Price1Lot Size
Ocugen Stock Forum
Grabbed a few at .88. It usually hovers around $1-2, a little upside
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease
Ocugen Announces Compelling Preliminary Data for Ocu410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
No comment yet